HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

polypropylene glycol (poly(propylene oxide))

Also Known As:

poly(propylene oxide); laprol-702; polyoxypropylene; polyoxypropylenediol

Networked: 32 relevant articles (2 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - polypropylene glycol: 32
Biomedical and Dental Materials
- Polymers: 13051
  - polypropylene glycol: 32
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - polypropylene glycol: 32
Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Propylene Glycols: 2
      - polypropylene glycol: 32

Experts

1.	Cuestas, María L: 2 articles (11/2012 - 08/2011)
2.	Mathet, Verónica L: 2 articles (11/2012 - 08/2011)
3.	Sosnik, Alejandro: 2 articles (11/2012 - 08/2011)
4.	Batrakova, Elena V: 2 articles (05/2010 - 01/2005)
5.	Kabanov, Alexander V: 2 articles (05/2010 - 01/2005)
6.	Li, Tao: 1 article (10/2021)
7.	Yang, Chaoqun: 1 article (10/2021)
8.	Barbera, Vincenzina: 1 article (05/2020)
9.	Cardile, Venera: 1 article (05/2020)
10.	Floresta, Giuseppe: 1 article (05/2020)

Related Diseases

1.	Weight Gain 10/01/2010 - "The results from gravimetric weight gain, surface characterization by contact angle measurements and ATR-IR spectroscopy, water flux measurements and protein adsorption revealed that poly(ethylene glycol)s (PEGs) were ineffective, while many nonionic amphiphilic substances, especially some tri-block copolymers of poly(ethyleneoxide) (PEO) and poly(propylene oxide) (PPO) were very effective for PP surface modification. "
2.	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/01/1999 - "With the aim of developing a gel formulation that could be effective in preventing sexually transmitted infections, the authors have evaluated the capacity of a polyoxypropylene/polyoxyethylene polymer to reduce or eliminate the toxicity of nonoxynol-9. "
3.	Spondylitis 01/01/2023 - "Retraction notice to "Transdermal delivery of flurbiprofen from polyoxypropylene-polyoxyethylene block copolymer stabilized reduced graphene oxide to manage pain in spondylitis: In vitro and in vivo studies" [European Journal of Pharmaceutical Sciences 165 (2021) 105929]." 10/01/2021 - "Transdermal delivery of flurbiprofen from polyoxypropylene-polyoxyethylene block copolymer stabilized reduced graphene oxide to manage pain in spondylitis: In vitro and in vivo studies."
4.	Pain (Aches) 01/01/2023 - "Retraction notice to "Transdermal delivery of flurbiprofen from polyoxypropylene-polyoxyethylene block copolymer stabilized reduced graphene oxide to manage pain in spondylitis: In vitro and in vivo studies" [European Journal of Pharmaceutical Sciences 165 (2021) 105929]." 10/01/2021 - "Transdermal delivery of flurbiprofen from polyoxypropylene-polyoxyethylene block copolymer stabilized reduced graphene oxide to manage pain in spondylitis: In vitro and in vivo studies."
5.	Breast Neoplasms (Breast Cancer) 09/01/2023 - "The present study investigates the encapsulation of a PI3-Kδ/HDAC6 dual inhibitor into hybrid block copolymers (polylactic acid-methoxy polyethylene glycol; polylactic acid-polyethylene glycol-polypropylene glycol-polyethylene glycol-polylactic acid) (HSB-510) as a delivery system to target PI3-Kδ and HDAC6 pathways in breast cancer cells. " 08/01/2011 - "The aim of this study was to investigate the inhibitory effect of different concentrations of pH- and temperature-responsive X-shaped poly(ethylene oxide)-poly(propylene oxide) block copolymers (poloxamines, Tetronic, PEO-PPO) showing a wide range of molecular weights and EO/PO ratios on the functional activity of three different ABC proteins, namely P-glycoprotein (P-gp or MDR1), breast cancer resistance protein (BCRP), and multidrug resistance-associated protein MRP1, in two human hepatocarcinoma cell lines, HepG2 and Huh7. "

Related Drugs and Biologics

1.	Polyethylene Glycols (Polyethylene Glycol)
2.	Proteins (Proteins, Gene)
3.	Polymers
4.	Ethylene Glycol (Monoethylene Glycol)
5.	Nonoxynol (Nonoxynol 9)
6.	Ethylene Oxide (Oxirane)
7.	Poloxamer (Poloxamer 407)
8.	Flurbiprofen (Froben)
9.	graphene oxide
10.	Hydrogels

Related Therapies and Procedures

1.	Intravenous Administration
2.	Topical Administration